Previous Article | Next Article ![]()
Journal of Virology, October 2003, p. 10594-10605, Vol. 77, No. 19
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.19.10594-10605.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544-1014,1 Biomedical Imaging Core Laboratory, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-61422
Received 24 April 2003/ Accepted 1 July 2003
|
|
|---|
|
|
|---|
In virions, the double-stranded HCMV DNA resides within a capsid that is surrounded first by a tegument layer and then by an envelope. The tegument domain, which is unique to herpesvirus particles, contains approximately 30 virus-encoded proteins (1, 5, 14). Since they are components of virions, tegument proteins are delivered to cells at the very start of infection and they have the potential to function even before the viral genome is activated. For example, the UL83-encoded pp65 protein has been reported to block major histocompatibility complex class I presentation of a viral immediate-early protein (21), the UL47 protein acts during disassembly of the newly infecting virus particle (8), the UL82-encoded pp71 protein is a transcriptional activator (32) that helps to activate the immediate-early genes within infected cells (10), and the UL69 protein blocks cell cycle progression (23).
The pp28 protein of HCMV (31, 36) is a 190-amino-acid myristylated (51) phosphoprotein (39) that is expressed as a true late protein (28, 37), i.e., it is synthesized only after the onset of viral DNA replication. The pp28 protein is encoded by UL99, the last open reading frame positioned within a family of 3'-coterminal transcripts that share the same polyadenylation site (61) (Fig. 1A). It is one of the most abundant constituents of the tegument layer (5, 31) and is highly immunogenic (30, 39, 44).
![]() View larger version (31K): [in a new window] |
FIG. 1. Diagrams of the HCMV genome, the region encoding UL99, and the mutations introduced into the UL99 coding region. (A) Map of the viral genome showing the location of UL93 to UL99 mRNAs. Repeated regions are represented by rectangles, unique regions (UL and US) are shown by a double line, and mRNAs are depicted by arrows. (B) Changes introduced into viral mutants. In BADsubUL99, a kanamycin-resistance marker is substituted for a substantial portion of the UL99 coding region, and in BADpmUL99, the UL99 ATG start codon is changed to TTG without altering the coding potential of the overlapping UL98 open reading frame, which is translated in a different reading frame.
|
In this study, we have investigated the function of pp28 during viral replication. Using a bacterial artificial chromosome (BAC) carrying the HCMV genome (62), we constructed two pp28-null mutants, a substitution mutant, and a point mutant. The mutants can be propagated only in a pp28-expressing cell line. Characterization of their growth in normal fibroblasts revealed that pp28 is required at a late step in the HCMV replication cycle, during the envelopment of capsids in the cytoplasm.
|
|
|---|
Mutant viruses unable to express pp28 and a revertant of one of the mutants were constructed by using the wild-type HCMV strain AD169 BAC(pAD12-29) (62). Alterations were made in pAD12-29 by allelic exchange with pGS284 (54). To alter the UL99 coding region in pAD12-29, three pGS284 derivatives were made: pGS284-KAN/UL99, pGS284-ATG-TTG/UL99, and pGS284-WT/UL99. pGS284-Kan/UL99 contains a kanamycin resistance gene cloned into the plasmid's BglII and NotI sites between PCR-amplified UL99-specific flanking sequences (nucleotides 143410 to 144478 and 144971 to 145996) (sequence numbers are from reference 13). pGS284-WT/UL99 carries an HCMV fragment containing the wild-type UL99 open reading frame (nucleotides 143782 to 144988). pGS284-ATG-TTG/UL99 has a UL99 allele that contains an A-to-T change at nucleotide 144392. This mutation changes the UL99 start codon from ATG to TTG, but it does not change the amino acid sequence of UL98, which overlaps UL99 by 61 bp (nucleotides 144393 to 144454) in a different reading frame. The integrity of the HCMV segment in each plasmid was confirmed by DNA sequence analysis. Allelic exchange was performed by homologous recombination in Escherichia coli GS500 cells as described previously (54, 62). BADsubUL99 (BAD is BAC-derived AD169) was made by recombination of pAD12-29 with pGS284-KAN/UL99 followed by selection and screening for kanamycin resistance. BADsubUL99 was used to make BADpmUL99 and BADrevUL99 by using pGS284-ATG-TTG/UL99 and pGS284WT/UL99, respectively, by screening for kanamycin sensitivity. The mutant BAC DNAs were analyzed by EcoRI and HindIII digestion and by Southern blot assay with probes to UL98, UL99, and the kanamycin resistance gene.
BAC DNAs (15 µg) were used to transfect HFFs and HFFpp28 cells in the presence of a plasmid expressing pp71 (1 µg) (27), which enhances the infectivity of HCMV DNA (4), and a cre-expressing plasmid (1 µg) to direct excision of the BAC sequences from the viral genome (54, 55) by electroporation. Virus stocks were prepared and infectious yields were determined by plaque assay on HFFpp28-8x cells. DNAs were prepared from infected cells and characterized by Southern blot analysis with probes for the UL82 and UL99 coding regions.
For analysis of mutant virus growth kinetics, HFFs and HFFpp28 cells were infected at a multiplicity of infection of 0.01 PFU/cell with BADwt (from the parental pAD12-29 BAC), BADsubUL99, BADpmUL99, or BADrevUL99 virus. At various times after infection, intracellular and extracellular viruses were collected by scraping the cells, disrupting them by sonication, pelleting the debris, and collecting the supernatant. Virus titers were determined by plaque assay on HFFpp28-8x cells.
The relative ratios of infectivity to number of virus particles was determined for BADwt and BADsubUL99 virions by using real-time PCR to quantify the amount of viral DNAs present in portions of virus stocks containing 103 PFU. The virus stocks were prepared by disrupting infected cells by sonication, pelleting the debris, and collecting the supernatant. The virus particles were incubated in lysis buffer (20 mM Tris-HCl, 50 mM EDTA, 200 mM NaCl, 1.2% sodium dodecyl sulfate [SDS], 200 µg of proteinase K/ml) for 2 h at 37°C, and the DNA was extracted with phenol-chloroform-isoamyl alcohol (24:24:1) and resuspended in TE buffer (pH 8.0) (10 mM Tris-HCl, 1 mM EDTA). Two dilutions from each viral DNA were amplified by using the iCicler iQ System (Bio-Rad), and the fluorescence from incorporated SYBR Green (Applied Biosystems) was measured at the end of each cycle. A portion of the UL10 open reading frame was arbitrarily chosen for amplification with the following primers: TGCGGCGACTGATTAACCATATC and AGGGTAACTGGATCACCTACTCTG.
Analysis of viral DNA and protein. Viral DNA was analyzed by Southern blot assay. Cell lysates were prepared in a lysis buffer containing 100 mM NaCl, 10 mM Tris (pH 8.0), 25 mM EDTA, 0.5% SDS, and 0.1 mg of proteinase K/ml. After incubation for 3 h at 55°C, DNA was extracted twice with phenol-chloroform-isoamyl alcohol (24:24:1), precipitated with ethanol, and resuspended in TE buffer. After digestion with restriction enzymes, DNA was analyzed by Southern blotting with UL99- or UL82-specific [32P]dCTP-labeled DNA probes.
Viral DNA accumulation was monitored by slot blot assay. Fibroblasts were infected with BADwt, BADsubUL99, or BADpmUL99 at a multiplicity of infection of 0.01 PFU/cell. At various times after infection, total cellular DNA was prepared as described above, and aliquots (1 µg) were transferred to a nylon membrane by using a slot blot apparatus. The immobilized viral DNA was hybridized to a 32P-labeled pp71-specific DNA probe, and after washing, radioactive probe retained on the membrane was quantified by using a phosphorimager.
The accumulation of viral proteins in HCMV- and recombinant retrovirus-infected cells was assayed by Western blotting. At various times after infection, cells lysates were dissolved in RIPA lysis buffer (10 mM Tris [pH 7.4], 1% Triton X-100, 0.1% SDS, 1% deoxycholate, 160 mM NaCl, and a protease inhibitor cocktail; Roche). Protein was quantified in the lysate by Bradford assay, and aliquots of protein (40 µg) were mixed with a 2x sample buffer and separated in SDS-containing 10% polyacrylamide gels. The separated proteins were transferred to a nitrocellulose membrane and probed with antibodies specific for the following viral and cellular proteins: UL123-encoded IE1 (1B12 monoclonal antibody produced by immunization with a fusion protein containing the C-terminal domain of IE1) (A. Marchini, P. Robinson, and T. Shenk, unpublished data), pUL44 (ICP36; Virusys), UL82-encoded pp71 (10G11) (27), UL97 (gift from A. Marchini, Tribeca Pharmaceuticals), UL99-encoded pp28 (10B4-29 monoclonal antibody produced by immunization with disrupted virions) (M. Silva, P. Robinson, and T. Shenk, unpublished data), UL83-encoded pp65 protein (41), and tubulin (DM1A; Sigma). Anti-mouse immunoglobulin G antibody conjugated with horseradish peroxidase was used as the secondary antibody.
Immunofluorescence and electron microscopic observation of infected cells. For immunofluorescence, fibroblasts grown on glass coverslips were infected with BADwt or BADsubUL99 at a multiplicity of infection of 0.01 PFU/cell. At 120 h postinfection, cells were washed twice with phosphate-buffered saline (PBS) at 37°C, fixed at room temperature with 2% paraformaldehyde in PBS for 20 min, and washed twice again with PBS. The fixed cells were permeabilized by treatment for 15 min at room temperature with PBS containing 0.1% Triton X-100, washed twice with PBS, and blocked by incubation for 30 min at room temperature with PBS containing 2% bovine serum albumin and 0.05% Tween 20. Cells were incubated at room temperature with primary antibody diluted in PBS containing 0.05% Tween 20 for 1 h, washed three times with buffer lacking the antibody, incubated with fluorochrome-conjugated anti-mouse or anti-rabbit secondary antibody for 1 h, and washed again three times. In some cases, after reacting with the secondary antibody, the Golgi compartment was stained by incubation of cells at room temperature with Alexa 488-conjugated lectin HPA (Molecular Probes) for 20 min. Coverslips were mounted in slow-fade solution (Molecular Probes) and analyzed by confocal microscopy. Primary antibodies used in these studies were UL32-encoded pp150 and UL83-encoded pp65 rabbit polyclonal antibodies (gift of M. Schrader, University of Marburg), UL99-encoded pp28 mouse monoclonal antibody (10B4-29), UL55-encoded gB (58-15 monoclonal antibody produced by immunization with disrupted virions) (P. Robinson and T. Shenk, unpublished data).
For electron microscopy, fibroblasts were infected with BADwt or BADsubUL99 at a multiplicity of infection of 0.01 PFU/cell. At 96 h postinfection, cells were washed with PBS and fixed with prewarmed 2.5% glutaraldehyde, 2 mM CaCl2, and 0.1 M sodium cacodylate (pH 7.4) for 2 h. The cells were rinsed in 0.1 M cacodylate buffer, collected from the culture plate in 1 ml of the same buffer, and centrifuged into a compact pellet. Cells were then treated with 1% osmium tetroxide, dehydrated with ascending concentrations of ethanol, embedded in LX-112 medium, and polymerized at 68°C for 72 h. Ultrathin sections (
80 nm) were cut with a diamond knife, mounted on 200-mesh thin-bar copper grids, stained with uranyl acetate and lead citrate, and examined with a Philips CM-100 electron microscope operated at 60-kV accelerating voltage.
|
|
|---|
After construction of the BAC derivatives, they were shown to be free of gross rearrangements by digestion with HindIII, and the region containing the mutation was shown to have the predicted structure by Southern blot assay with probes for UL98, UL99, and, in the case of BADsubUL99, a probe for the kanamycin resistance gene (data not shown). The BAC DNAs were introduced into human fibroblasts by electroporation, and virus was recovered from BAC DNA containing the wild-type HCMV genome, BADwt, and the revertant, BADrevUL99. However, BAC DNAs containing the BADsubUL99 or BADpmUL99 genome did not produce infectious virus when introduced into human fibroblasts, suggesting that pp28 is required for HCMV replication.
To rescue the growth of the mutant viruses, we prepared complementing cells that expressed pp28 from an integrated defective retrovirus. A recombinant retrovirus carrying the UL99 coding region (RetroUL99) grew poorly and produced relatively low-titer virus stocks (data not shown). Consequently, it was necessary to infect fibroblasts multiple times with RetroUL99 to increase the number of integrated recombinant retrovirus genomes in order to obtain sufficient expression of pp28 for complementation. The number of sequential infections correlated with the proportion of the fibroblast population expressing the protein. Three or eight sequential infections produced fibroblast populations termed HFFpp28-3x and HFFpp28-8x, in which about 30 and 80% of the cells, respectively, expressed pp28 at a level that could be detected by immunofluorescence (data not shown). We determined the levels of pp28 expressed and the growth efficiency of BADsubUL99 in these two cell populations. Western blot analysis demonstrated that HFFpp28-8x cultures expressed about five times more pp28 than HFFpp28-3x (Fig. 2A, left panel). The amount of the protein expressed by HFFpp28-8x cultures was comparable to that produced during the late phase of infection (120 h postinfection) in cultured fibroblasts, in which about 1% of the cells were infected with wild-type HCMV (Fig. 2A, right panel). Since about 80% of the cells in HFFpp28-8x cultures express pp28, as can be detected by immunofluorescence, the level of pp28 expression in each cell is substantially lower in HFFpp28-8x cells than in HCMV-infected cells. Nevertheless, the two pp28-deficient viruses, BADsubUL99 and BADpmUL99, were recovered from BAC DNAs following electroporation into HFFpp28-8x cells. BADsubUL99 grew to 10-fold-higher titers in HFFpp28-8x than in HFFpp28-3x (Fig. 2B).
![]() View larger version (43K): [in a new window] |
FIG. 2. Characterization of complementing cells and analysis of the structure of mutant DNAs derived from pp28-deficient virus produced in complementing cells. (A) Western blot analysis monitoring the expression of pp28 in mock-infected (M), HFFpp28-3x cells (3x), HFFpp28-8x cells (8x), and HCMV-infected fibroblasts (HFF) at different times (hours) postinfection (hpi). WT, wild type. (B) Growth of BADsubUL99 in HFFpp28-3x cells (3x), HFFpp28-8x cells (8x), and normal fibroblasts (HFF). Cells were infected, lysates of cells were prepared in the culture medium at the indicated times after infection, and virus was quantified by plaque assay on HFFpp28-8x cells. (C) Location of native pp28 and HA-tagged pp28 expressed from recombinant retroviruses in fibroblasts. Immunofluorescence was performed by using a pp28-specific antibody on HFFpp28-8x (bottom) cells and cells expressing HA-tagged pp28 (HFFHA-pp28, top). Three images are presented for each cell type: left, pp28 (green); middle, nuclear stain (red); right, multicolor merge. (D) Southern blot assay of viral DNAs. Total cell DNA was prepared from HFFpp28-8x cells infected with the indicated viruses, and DNA was cleaved with HindIII and analyzed by Southern blot assay with a UL82- and UL99-specific probe DNA. The sizes of labeled DNA fragments are indicated in kilobases relative to marker (M) DNA fragments.
|
To exclude the possibility of contamination with wild-type virus and to verify the changes in the substitution mutant and revertant virus genomes recovered from complementing cells, we performed Southern blot assays. HindIII-digested viral DNAs were analyzed with a UL99-specific probe (Fig. 2D, right panel) or, as a control, with a UL82-specific probe (Fig. 2D, left panel). The expected UL99-specific bands of 6.6 kb in BADwt and BADpmUL99 and 1.8 kb in BADsubUL99 were obtained. The structure of BADpmUL99 was confirmed by sequence analysis of the viral DNA in the region containing the point mutation (data not shown).
The growth kinetics of the mutant and revertant viruses were compared on normal human fibroblasts and HFFpp28-8x cells (Fig. 3A). Cells were infected at a multiplicity of infection of 0.01 PFU/cell, and virus yields were determined by plaque assay on HFFpp28-8x cells. BADrevUL99 grew to the same titers as BADwt in normal fibroblasts and in HFFpp28-8x cells, indicating that the defect in BADsubUL99 is caused by the specific changes made in the UL99 coding region and not by unintentional alterations in other regions of the viral genome. No infectious progeny virus was detected after BADsubUL99 or BADpmUL99 infection of human fibroblasts, which do not express pp28. Even in HFFpp28-8x cells, both mutants produced substantially reduced virus yields compared to wild-type or revertant viruses. Presumably, pp28 levels are limiting in the complementing cells, and as a result, the mutants do not produce wild-type yields. This interpretation is consistent with the observation that BADsubUL99 grows less well in HFFpp28-3x than in HFFpp28-8x cells (Fig. 2B).
![]() View larger version (38K): [in a new window] |
FIG. 3. Growth characteristics and relative particle-to-PFU ratios of wild-type (wt) and pp28-deficient viruses. (A) Production of infectious progeny in cultures of pp28-expressing fibroblasts (HFFpp28-8x) or normal fibroblasts (HFF). Cells were infected with BADwt (), BADrevUL99 ( ), BADsubUL99 ( ), or BADpmUL99 ( ) at a multiplicity of infection of 0.01 PFU/cell. Cells were lysed in culture medium at the indicated times after infection, and virus was quantified by plaque assay on HFFpp28-8x cells. (B) Relative amounts of DNA in BADsubUL99 compared to BADwt virions. DNA was prepared from a quantity of virus stock containing 103 PFU, and aliquots of undiluted DNA and diluted (1:25) DNA were quantified by real-time PCR with a primer pair that amplified a segment of the HCMV UL10 gene. Relative fluorescence units (RFU) are plotted as a function of cycle number.
|
Since it appears likely that the amount of pp28 is limiting in complementing cells, we investigated the possibility that large numbers of noninfectious particles, containing no pp28 or reduced amounts of pp28, were present in BADsubUL99 virus stocks. The number of infectious particles relative to the total number of particles, estimated from the amount of viral DNA, produced was analyzed by quantitative real-time PCR. We detected 2 to 5 times more DNA in aliquots of BADsubUL99 virus stocks that contained 103 PFU than in similar samples of BADwt (Fig. 3B). Although it appears that BADsubUL99 virus stocks contain somewhat more DNA-containing particles per unit of infectivity than BADwt stocks, the difference is modest relative to the growth defect observed for the mutant in normal fibroblasts. Indeed, it is possible that the mutant particles are as infectious as wild-type virions, because the titer of BADsubUL99 might be underestimated by plaque assay on HFFpp28-8x cells.
Mutant viruses lacking pp28 have a defect at a late stage of viral replication. To determine whether the block to the growth of the pp28-deficient mutants was at an early or late stage of the viral replication cycle, we monitored the accumulation of viral DNA. Normal fibroblasts were infected at a multiplicity of infection of 0.01 PFU/cell, total DNA was prepared at intervals from days 1 to 5 after infection, and a slot blot assay was performed with an HCMV-specific probe. In two independent experiments, BADsubUL99 and BADpmUL99 DNAs accumulated at rates comparable to that observed for BADwt virus (Fig. 4). Although a modest difference between the mutant and wild-type viruses was evident on day 5 after infection, this difference can be explained by the fact that wild-type virus is completing its replication cycle and infecting new cells at this time, whereas the mutant viruses are not.
![]() View larger version (26K): [in a new window] |
FIG. 4. Accumulation of viral DNA after infection with wild-type (wt) and pp28-deficient viruses. Normal fibroblasts were infected with BADwt (), BADsubUL99 ( ), or BADpmUL99 ( ) at a multiplicity of infection of 0.01 PFU/cell, and total cell DNA was prepared at the indicated times after infection and assayed by slot blot with an HCMV-specific probe. Radioactivity was quantified by using a phosphorimager.
|
![]() View larger version (48K): [in a new window] |
FIG. 5. Accumulation of viral proteins after infection with wild-type (wt) and pp28-deficient viruses. Normal fibroblasts were mock-infected (M) or infected with BADwt, BADsubUL99, or BADpmUL99 at a multiplicity of infection of 0.01 PFU/cell, and whole-cell extracts were prepared at 72 h (A) or at the indicated times after infection (days postinfection [dpi]) (B). Proteins were analyzed by Western blot analysis with antibodies specific for the UL123-encoded IE1, pUL97, UL83-encoded pp65, UL82-encoded pp71, pUL44, or UL99-encoded pp28.
|
Finally, we monitored expression of a true late protein (12), pp65, at 1 to 6 days after infection with the BADsubUL99, BADpmUL99, BADwt, or BADrevUL99 virus, and again, there was little or no difference in the accumulation of the viral protein among the viruses (Fig. 5B).
Envelopment of capsids within the cytoplasm requires pp28. The late viral proteins (pp65, pp71, and UL97) that we examined proved to accumulate to normal or nearly normal levels after infection with pp28-deficient virus. Although we examined only a small subset of viral proteins, this result raised the possibility that the defect in mutant virus-infected cells might reside at the level of virus assembly. Consequently, we examined the morphogenesis of virions at 96 h after infection of normal fibroblasts with BADwt or BADsubUL99 by electron microscopy. All three types of capsids, A (empty), B (protein scaffold containing), and C (DNA containing), were evident in the nuclei of wild-type and mutant virus-infected cells (Fig. 6A). The number of each capsid type was counted in nuclear sections derived from different infected cells. Five sections from BADwt-infected nuclei contained 105 A, 241 B, and 106 C capsids, whereas five sections from BADsubUL99-infected nuclei contained 105 A, 226 B, and 186 C capsids. The pp28-deficient mutant and wild-type virus produced similar numbers and ratios (within twofold) of the three different capsids within the nucleus.
![]() View larger version (187K): [in a new window] |
FIG. 6. Accumulation of virus particles in normal fibroblasts infected with wild-type (wt) and pp28-deficient viruses. Cells were infected with BADwt or BADsubUL99 at a multiplicity of infection of 0.01 PFU/cell and processed for electron microscopy 96 h later. Images were printed at a final magnification of x56,000. Representative infected nuclear (A) and cytoplasmic (B) regions are shown. Arrows identify enveloped virions in the cytoplasm of wild-type virus-infected cells and capsids in mutant-infected cytoplasm.
|
Mock-infected and mutant virus-infected cells are compared in Fig. 7. Approximately 240 cytoplasmic capsids were counted in the cytoplasmic section of the BADsubUL99-infected cell, but no enveloped particles were seen.
![]() View larger version (143K): [in a new window] |
FIG. 7. Comparison of mock-infected and pp28-deficient virus-infected cells. Cells were mock-infected (A) or infected with BADsubUL99 at a multiplicity of infection of 0.01 PFU/cell (B) and processed for electron microscopy at 96 h postinfection. Images were printed at a final magnification of x13,600. The nucleus (nuc) and cytoplasm (cyt) are identified.
|
![]() View larger version (52K): [in a new window] |
FIG. 8. Localization of viral proteins expressed in normal fibroblasts infected with wild-type (WT) and pp28-deficient viruses. Cells were infected with BADwt or BADsubUL99 at a multiplicity of infection of 0.01 PFU/cell and processed for immunofluorescence at 120 h postinfection. Four images are presented for each cell. The upper-left quadrant shows UL32-encoded pp150 (A), UL83-encoded pp65 (B), or UL55-encoded gB (C) in red. The lower-left quadrants of panels A and B display pp28 in blue, whereas the lower-left panel of C contains blue-stained nuclei. In all panels, the upper-right quadrant displays Golgi in green and the lower-right panel shows a multicolored merged image.
|
|
|
|---|
HCMV tegument proteins that accumulate in the cytoplasm late after infection include the UL32-encoded pp150 (24, 50), the UL99-encoded pp28 (31), the UL83-encoded pp65 (24, 50), and the UL25-encoded pUL25 (6). These, and presumably other tegument proteins, associate with the capsid in the cytoplasm, and then the complex acquires an envelope containing virus-specific glycoproteins. Electron microscopic studies demonstrate that tegument-coated particles acquire an envelope by budding into cytoplasmic vacuoles (20, 52, 56, 57). Immunofluorescence assays have suggested that the site of cytoplasmic envelopment is a juxtanuclear structure that includes viral tegument proteins as well as multiple virus-encoded envelope proteins (50). Using antibodies to cellular proteins, the cytoplasmic assembly center has been shown to partially overlap with a component of the trans-Golgi network (50), and we similarly observed that the location of viral proteins involved in the cytoplasmic assembly step partially overlapped with a Golgi marker (Fig. 8). Recently, Homman-Loudiyi et al. (26) have shown that the UL55-encoded gB, a major glycoprotein constituent of the HCMV envelope, colocalizes with several protein markers of Golgi-derived vacuoles that are destined for the plasma membrane. Consequently, it appears that the juxtanuclear HCMV assembly site is comprised of modified elements of the secretory apparatus. This view is reinforced by the ability of brefeldin A to block the envelopment of HCMV capsids (18), similar to the block it institutes in other herpesviruses (e.g., herpes simplex virus [15] and pseudorabies virus [60]).
In this report we have demonstrated that the pp28 protein plays a key role in the cytoplasmic phase of HCMV assembly. To study the function of pp28, we constructed two mutant viruses, BADsubUL99 and BADpmUL99 (Fig. 1B), which failed to produce pp28 (Fig. 5 and 8) and were defective for growth in normal fibroblasts (Fig. 3A). Viral DNA accumulated with wild-type kinetics reaching wild-type levels within mutant virus-infected cells (Fig. 4), several late proteins that were monitored by Western blot (Fig. 5) or immunofluorescence (Fig. 8) accumulated to wild-type levels, and numerous capsids accumulated in the nucleus of infected cells (Fig. 6A). However, once capsids reached the cytoplasm of mutant virus-infected cells, they did not associate with membranes of vesicles and, consequently, they did not acquire an envelope (Fig. 6B and 7). The phenotype of the pp28 mutants provides compelling support for the assembly model in which the HCMV capsid-tegument complex acquires its final envelope by budding through a secretory membrane within the cytoplasm.
BADsubUL99 capsids in the cytoplasm contained a thickened electron-dense coating compared to nuclear capsids (Fig. 6 and 7). This argues that, in the absence of pp28, capsids associate with tegument proteins but fail to bud through a membrane. It is interesting that Landini et al. (31) localized pp28 to the periphery of cytoplasmic capsids by electron microscopic examination of immunogold-labeled cells that were infected with HCMV. The label was not evident on vacuole membranes, where encapsidation is thought to occur (reference 26 and references therein), suggesting that pp28 might first interact with a capsid-tegument complex and then direct it to an appropriately modified membrane for envelopment. Further, pp28 forms a detergent-resistant association with capsids, suggesting it is more firmly associated with capsids than tegument proteins such as pp65 whose association is substantially disrupted by detergent treatment of virions (20).
Since we have monitored the expression of a limited subset of the late genes in mutant virus-infected cells, it is possible that pp28 influences the assembly process indirectly by stimulating the production of another HCMV late protein that was not assayed. However, pp28 is not known to modulate gene expression. We favor the view that pp28 acts directly to mediate the cytoplasmic envelopment of capsids for two reasons. First, pp28 is localized to the region within the cytoplasm at which assembly takes place in HCMV-infected cells (Fig. 8). Second, pp28 is a myristylated protein that interacts with cellular membranes (51). Studies of retrovirus assembly have revealed that myristylation of the gag protein is required for its targeting to cellular membranes with the concomitant budding of subviral particles to acquire an envelope (11, 46). Our results suggest that myristylation is required for pp28 function, since cells expressing HA-pp28, which cannot be myristylated, do not complement the defect of pp28-deficient viruses (Fig. 2).
It has been shown that, when expressed from a transfected plasmid in Cos7 cells, the pp28 viral tegument protein colocalized with a protein that resides in the endoplasmic reticulum-Golgi intermediate compartment (51), a compartment of the secretory pathway in which glycoproteins are sorted and transferred from the endoplasmic reticulum to the Golgi complex (reviewed in reference 22). However, in the context of viral infection, pp28 is relocated to the proposed assembly region in which other tegument proteins and glycoproteins are localized (51), indicating that interaction with other viral proteins or cellular proteins induced by infection is necessary for the proper localization of pp28. We tested the localization of other viral structural proteins to the cytoplasmic assembly site in the absence of pp28, but at the resolution of immunofluorescence, the pp150 and pp65 tegument proteins and the gB envelope glycoprotein were properly localized (Fig. 8). One might speculate that pp150, pp65, and other tegument proteins are directed to the assembly site by interacting, either directly or indirectly, with the cytoplasmic tails of virus-encoded envelope proteins like gB; it is also possible that these proteins interact with the capsid as well as the membrane assembly sites. Indeed, pp150 has been shown to bind directly to capsids (7, 58).
The BADsubUL99 and BADpmUL99 mutant viruses are extremely defective for growth in normal fibroblasts, producing no detectable infectious progeny (Fig. 2B and 3A). Since it is possible that plaque formation by the mutant viruses on the complementing cells is inefficient, we also assayed lysates of BADsubUL99-infected fibroblasts for the presence of virus able to infect cells and express the HCMV IE1 protein, but again, we obtained no evidence for the production of infectious progeny virus. The loss of pp28 leads to a complete block in the virus replication cycle. The strong dependence of viral growth on pp28 function is consistent with the observation that the sequence of the pp28 protein encoded by the Towne strain of HCMV is very similar to that of the AD169 protein (42) and with the presence of pp28 homologues in chimpanzee (17) and murine cytomegaloviruses (16, 45).
In addition to their failure to produce infectious progeny in normal human fibroblasts, the pp28-deficient mutants grew poorly in complementing cells (Fig. 3A). It is not likely that the mutant viruses contain a second site mutation because two different pp28-deficient mutants, BADsubUL99 and BADpmUL99, were generated, and both grew to the same limited extent in the complementing cells. Further, a revertant of BADsubUL99, termed BADrevUL99, grew like the wild-type virus, ruling out the possibility that the mutant phenotype resulted from a change at another location (Fig. 3A). The level of the pp28 protein is substantially reduced in the complementing cells compared to infected cells (Fig. 2A), and increasing amounts of pp28 (HFFpp28-3x versus HFFpp28-8x cells) supported the production of an increased yield of BADsubUL99 (Fig. 2B). Apparently, the poor growth of the mutant viruses in the complementing cells results from limiting amounts of pp28.
In some respects, the HCMV pp28 protein is functionally similar to the protein encoded by the herpes simplex type 1 UL11 gene. Both proteins are relatively small phosphoproteins (pp28, 190 amino acids; UL11, 96 amino acids), myristylated (34, 51), membrane associated (9, 35, 51), and tegument proteins (31, 51). The UL11 protein is also palmitylated (33), and it is not known if pp28 undergoes this modification. Further, as for the mutants described here (Fig. 6 and 7), a herpes simplex virus mutant unable to express the UL11 protein accumulated increased numbers of capsids in the nucleus and cytoplasm (3). However, there are significant differences between the two viral gene products. We have found that the growth phenotype of pp28-deficient mutants is extreme, i.e., no infectious virus can be detected after infection of normal fibroblasts (Fig. 3A). In contrast, UL11-deficient mutants grow poorly but nevertheless produce infectious progeny (3, 35). Further, whereas pp28 appears to be localized exclusively to the cytoplasm (51), UL11 is found in both the nuclear and cytoplasmic compartments of infected cells (2). Finally, HCMV can grow efficiently in pp28-expressing cells (Fig. 3A), but UL11-expressing cells are resistant to infection with herpes simplex virus, apparently at the point of fusion of the virion's envelope and the plasma membrane (48). It is possible that higher-level expression of pp28 might interfere with infection by wild-type virus, but at the level of expression we have achieved, we detect no inhibition. Additional experimentation will be needed to better delineate the functional similarities and differences between pp28 and the UL11 protein.
In conclusion, our mutant analysis has demonstrated that pp28 is required for the final cytoplasmic envelopment of tegument-associated HCMV capsids.
This work was supported by a grant from the NIH (CA82396), and M.C.S. was supported by a predoctoral fellowship from the Brazilian government (Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq).
|
|
|---|
deenvelopment
reenvelopment pathway. J. Virol. 75:5697-5702.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»